UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: A population-based study

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 357.e1-357.e5

  Chiò, Adriano ^a   Mora, Gabriele ^b   Restagno, Gabriella ^c   Brunetti, Maura ^c   Ossola, Irene ^c   Barberis, Marco ^c   Ferrucci, Luigi ^d   Canosa, Antonio ^a   Manera, Umberto ^a   Moglia, Cristina ^a   Fuda, Giuseppe ^a   Traynor, Bryan J ^d   Calvo, Andrea ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b IRCCS   (Italy)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Amyotrophic lateral sclerosis; Prognosis; Risk factor; UNC13A

Indexed keywords

EID: 84868096807     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.07.016     Document Type: Article

References (24)

1. Augustin I., Rosenmund C., Südhof T.C., Brose N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 1999, 400:457-461.
2. Broeke J.H., Roelandse M., Luteijn M.J., Boiko T., Matus A., Toonen R.F., Verhage M. Munc18 and Munc13 regulate early neurite outgrowth. Biol. Cell 2010, 102:479-488.
3. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord 2000, 1:293-299. World Federation of Neurology Research Group on Motor Neuron Diseases.
4. Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., Heverin M., Jordan N., Kenna K., Lynch C., McLaughlin R.L., Iyer P.M., O'Brien C., Phukan J., Wynne B., Bokde A.L., Bradley D.G., Pender N., Al-Chalabi A., Hardiman O. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9ORF72 repeat expansion: a population-based cohort study. Lancet Neurol 2012, 11:232-240.
5. Chiò A., Borghero G., Restagno G., Mora G., Drepper C., Traynor B.J., Sendtner M., Brunetti M., Ossola I., Calvo A., Pugliatti M., Sotgiu M.A., Murru M.R., Marrosu M.G., Marrosu F., Marinou K., Mandrioli J., Sola P., Caponnetto C., Mancardi G., Mandich P., La Bella V., Spataro R., Conte A., Monsurrò M.R., Tedeschi G., Pisano F., Bartolomei I., Salvi F., Lauria Pinter G., Simone I., Logroscino G., Gambardella A., Quattrone A., Lunetta C., Volanti P., Zollino M., Penco S., Battistini S., Renton A.E., Majounie E., Abramzon Y., Conforti F.L., Giannini F., Corbo M., Sabatelli M. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 2012, 135:784-793. ITALSGEN Consortium.
6. Chiò A., Mora G., Calvo A., Mazzini L., Bottacchi E., Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009, 72:725-731. PARALS.
7. Chiò A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G. Prognostic factors in ALS: a critical review. Amyotroph. Lateral Scler 2009, 10:310-323. Eurals Consortium.
8. Daoud H., Belzil V., Desjarlais A., Camu W., Dion P.A., Rouleau G.A. Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis. Arch. Neurol 2010, 67:516-517.
9. Diekstra F.P., van Vught P.W., van Rheenen W., Koppers M., Pasterkamp R.J., van Es M.A., Schelhaas H.J., de Visser M., Robberecht W., Van Damme P., Andersen P.M., van den Berg L.H., Veldink J.H. UNC13A is a modifier of survival in amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:630.e3-630.e8.
10. Ferrucci L., Bandinelli S., Benvenuti E., Di Iorio A., Macchi C., Harris T.B., Guralnik J.M. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J. Am. Geriatr. Soc 2000, 48:1618-1625.
11. Jokic N., Gonzalez de Aguilar J.L., Dimou L., Lin S., Fergani A., Ruegg M.A., Schwab M.E., Dupuis L., Loeffler J.P. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep 2006, 7:1162-1167.
12. Kwee L.C., Liu Y., Haynes C., Gibson J.R., Stone A., Schichman S.A., Kamel F., Nelson L.M., Topol B., van den Eeden S.K., Tanner C.M., Cudkowicz M.E., Grasso D.L., Lawson R., Muralidhar S., Oddone E.Z., Schmidt S., Hauser M.A. A high-density genome-wide association screen of sporadic als in US veterans. PLoS One 2012, 7:e32768.
13. Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., Nalls M.A., Heckerman D., Tienari P.J., Traynor B.J. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: A genome-wide association study. Lancet Neurol 2010, 9:978-985.
14. Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996, 347:1425-1431.
15. Melzer D., Perry J.R., Hernandez D., Corsi A.M., Stevens K., Rafferty I., Lauretani F., Murray A., Gibbs J.R., Paolisso G., Rafiq S., Simon-Sanchez J., Lango H., Scholz S., Weedon M.N., Arepalli S., Rice N., Washecka N., Hurst A., Britton A., Henley W., van de Leemput J., Li R., Newman A.B., Tranah G., Harris T., Panicker V., Dayan C., Bennett A., McCarthy M.I., Ruokonen A., Jarvelin M.R., Guralnik J., Bandinelli S., Frayling T.M., Singleton A., Ferrucci L. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008, 4:e1000072.
16. Millecamps S., Boillée S., Le Ber I., Seilhean D., Teyssou E., Giraudeau M., Moigneu C., Vandenberghe N., Danel-Brunaud V., Corcia P., Pradat P.F., Le Forestier N., Lacomblez L., Bruneteau G., Camu W., Brice A., Cazeneuve C., Leguern E., Meininger V., Salachas F. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet 2012, 49:258-263.
17. O'Toole O., Traynor B.J., Brennan P., Sheenan C., Frost E., Corr B., Hardiman O. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J. Neurol. Neurosurg. Psychiatry 2007, 79:30-32.
18. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 2007, 81:559-575.
19. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol 1990, 28:8-25.
20. Sabatelli M., Conforti F.L., Zollino M., Mora G., Monsurrò M.R., Volanti P., Marinou K., Salvi F., Corbo M., Giannini F., Battistini S., Penco S., Lunetta C., Quattrone A., Gambardella A., Logroscino G., Simone I., Bartolomei I., Pisano F., Tedeschi G., Conte A., Spataro R., La Bella V., Caponnetto C., Mancardi G., Mandich P., Sola P., Mandrioli J., Renton A.E., Majounie E., Abramzon Y., Marrosu F., Marrosu M.G., Murru M.R., Sotgiu M.A., Pugliatti M., Rodolico C., Moglia C., Calvo A., Ossola I., Brunetti M., Traynor B.J., Borghero G., Restagno G., Chiò A. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol. Aging 2012, 33:1848.e15-1848.e20. ITALSGEN Consortium.
21. Shatunov A., Mok K., Newhouse S., Weale M.E., Smith B., Vance C., Johnson L., Veldink J.H., van Es M.A., van den Berg L.H., Robberecht W., Van Damme P., Hardiman O., Farmer A.E., Lewis C.M., Butler A.W., Abel O., Andersen P.M., Fogh I., Silani V., Chiò A., Traynor B.J., Melki J., Meininger V., Landers J.E., McGuffin P., Glass J.D., Pall H., Leigh P.N., Hardy J., Brown R.H., Powell J.F., Orrell R.W., Morrison K.E., Shaw P.J., Shaw C.E., Al-Chalabi A. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 2010, 9:986-994.
22. Traynor B.J., Nalls M., Lai S.L., Gibbs R.J., Schymick J.C., Arepalli S., Hernandez D., Van Der Brug M.P., Johnson J.O., Dillman A., Cookson M., Moglia C., Calvo A., Restagno G., Mora G., Chiò A. Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12335-12338.
23. Van Es M.A., Veldink J.H., Saris C.G., Blauw H.M., Van Vught P.W., Birve A., Lemmens R., Schelhaas H.J., Groen E.J., Huisman M.H., Van Der Kooi A.J., De Visser M., Dahlberg C., Estrada K., Rivadeneira F., Hofman A., Zwarts M.J., Van Doormaal P.T., Rujescu D., Strengman E., Giegling I., Muglia P., Tomik B., Slowik A., Uitterlinden A.G., Hendrich C., Waibel S., Meyer T., Ludolph A.C., Glass J.D., Purcell S., Cichon S., Nöthen M.M., Wichmann H.E., Schreiber S., Vermeulen S.H., Kiemeney L.A., Wokke J.H., Cronin S., McLaughlin R.L., Hardiman O., Fumoto K., Pasterkamp R.J., Meininger V., Melki J., Leigh P.N., Shaw C.E., Landers J.E., Al-Chalabi A., Brown R.H., Robberecht W., Andersen P.M., Ophoff R.A., Van Den Berg L.H. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet 2009, 41:1083-1087.
24. Yang Y., Calakos N. Munc13-1 is required for presynaptic long-term potentiation. J. Neurosci 2011, 31:12053-12057.